KEGG   DRUG: Tezacaftor and ivacaftorHelp
Entry
D11042            Mixture   Drug                                   

Name
Tezacaftor and ivacaftor;
Symdeko (TN)
Product
Component
Tezacaftor [DR:D11041], Ivacaftor [DR:D09916]
Remark
ATC code: R07AX31
Product: D11042<US>
Efficacy
Cystic fibrosis treatment
  Disease
Cystic fibrosis (CFTR F508del homozygous mutation) [DS:H00218]
Cystic fibrosis (at least one mutation in CFTR) [DS:H00218]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 R RESPIRATORY SYSTEM
  R07 OTHER RESPIRATORY SYSTEM PRODUCTS
   R07A OTHER RESPIRATORY SYSTEM PRODUCTS
    R07AX Other respiratory system products
     R07AX31 Ivacaftor and tezacaftor
      D11042  Tezacaftor and ivacaftor <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11042
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11042
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11042
Pharmacogenomic biomarkers [br08341.html]
 Germline mutations in genetic disorder treatments
  D11042
BRITE hierarchy
Other DBs
PubChem: 355052576
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system